0001209191-15-034045.txt : 20150414
0001209191-15-034045.hdr.sgml : 20150414
20150414171232
ACCESSION NUMBER: 0001209191-15-034045
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150413
FILED AS OF DATE: 20150414
DATE AS OF CHANGE: 20150414
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARTER BRUCE L A
CENTRAL INDEX KEY: 0001225503
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 15769904
MAIL ADDRESS:
STREET 1: C/O ZYMOGENETICS, INC.
STREET 2: 1201 EASTLAKE AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98102
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-04-13
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001225503
CARTER BRUCE L A
C/O REGULUS THERAPEUTICS INC.
3545 JOHN HOPKINS CT. #210
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2015-04-13
4
M
0
20000
4.78
A
20000
D
Common Stock
2015-04-13
4
S
0
20000
17.6582
D
0
D
Stock Option (Right to Buy)
4.78
2015-04-13
4
M
0
20000
0.00
D
2022-10-30
Common Stock
20000
10000
D
The weighted average sale price for the transaction reported was $17.6582, and the range of prices were between $17.65 and $17.685. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
25% of the shares will vest on October 31, 2013 and the remainder of the shares will vest in equal installments on a monthly basis thereafter, such that the option is fully vested on October 30, 2016.
Christopher Aker, Attorney in Fact
2015-04-14